By product type, the antibodies segment dominated the global life science products market in terms of revenue in 2017 and is projected to continue to do so throughout the forecast period. The antibodies segment is expected to be the most attractive segment by product type, with a market attractiveness index of 4.6 during the forecast period.

Market Analysis and Insights: Global Life Science Products Market
The global Life Science Products market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Life Science Products Scope and Market Size
Life Science Products market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Life Science Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Recombinant Proteins
Cell Lines
Antibodies
Viable Tumor Samples
Tumor Tissue Microarrays
Other

Segment by Application
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Forensic Science Laboratories
Food & Beverage Companies
Diagnostic Centers
Other

By Company
Merck Millipore Limited
PerkinElmer
Sigma Aldrich Corp
Thermo Fisher Scientific
Abcam
A.M.S. Biotechnology (Europe)
Bio-Rad Laboratories
BPS Bioscience
Crown Bioscience
Genscript Biotech Corporation

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia